Literature DB >> 20856709

Recent developments in medicare coverage of off-label cancer therapies.

.   

Abstract

Centers for Medicare & Medicaid Services has implemented a number of important changes during the last 18 months regarding use of the compendia and journals for determining medically accepted off-label indications.

Entities:  

Year:  2009        PMID： 20856709      PMCID： PMC2790627          DOI： 10.1200/JOP.0913001

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  1 in total

1.  Reimbursement for cancer treatment: coverage of off-label drug indications.

Authors: 
Journal:  J Clin Oncol       Date:  2006-05-22       Impact factor: 44.544
  1 in total
  5 in total

1.  Off-label.

Authors:  John V Cox
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

2.  Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.

Authors:  Rena M Conti; Arielle C Bernstein; Victoria M Villaflor; Richard L Schilsky; Meredith B Rosenthal; Peter B Bach
Journal:  J Clin Oncol       Date:  2013-02-19       Impact factor: 44.544

3.  Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study.

Authors:  M Joerger; C Schaer-Thuer; D Koeberle; K Matter-Walstra; J Gibbons-Marsico; S Diem; B Thuerlimann; T Cerny
Journal:  Eur J Clin Pharmacol       Date:  2014-03-11       Impact factor: 2.953

4.  News and Notes From the 2009 Carrier Advisory Committee Meeting: Medical Necessity, Off-Label Chemotherapy, and More.

Authors:  Barbara McAneny; Thomas Marsland; Kristen King
Journal:  J Oncol Pract       Date:  2009-11       Impact factor: 3.840

5.  Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study.

Authors:  Jeffrey Wagner; John Marquart; Julia Ruby; Austin Lammers; Sham Mailankody; Victoria Kaestner; Vinay Prasad
Journal:  BMJ       Date:  2018-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.